Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector

被引:904
作者
Szymczak, AL
Workman, CJ
Wang, Y
Vignali, KM
Dilioglou, S
Vanin, EF
Vignali, DAA
机构
[1] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Hematol Oncol, Div Expt Hematol, Memphis, TN 38105 USA
[3] Univ Tennessee, Med Ctr, Dept Pathol, Memphis, TN 38163 USA
[4] Univ Tennessee, Med Ctr, Grad Program Pathol, Memphis, TN 38163 USA
关键词
D O I
10.1038/nbt957
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Attempts to generate reliable and versatile vectors for gene therapy and biomedical research that express multiple genes have met with limited success. Here we used Picornavirus 'self-cleaving' 2A peptides, or 2A-like sequences from other viruses(1-3), to generate multicistronic retroviral vectors with efficient translation of four cistrons. Using the T-cell receptor: CD3 complex as a test system, we show that a single 2A peptide-linked retroviral vector can be used to generate all four CD3 proteins (CD3epsilon, gamma, delta, zeta), and restore T-cell development and function in CD3-deficient mice. We also show complete 2A peptide-mediated 'cleavage' and stoichiometric production of two fluorescent proteins using a fluorescence resonance energy transfer-based system in multiple cell types including blood, thymus, spleen, bone marrow and early stem cell progenitors.
引用
收藏
页码:589 / 594
页数:6
相关论文
共 30 条
  • [21] Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells
    Persons, DA
    Allay, JA
    Riberdy, JM
    Wersto, RP
    Donahue, RE
    Sorrentino, BP
    Nienhuis, AW
    [J]. NATURE MEDICINE, 1998, 4 (10) : 1201 - 1205
  • [22] Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer
    Pizzato, M
    Franchin, E
    Calvi, P
    Boschetto, R
    Colombo, M
    Ferrini, S
    Palu, G
    [J]. GENE THERAPY, 1998, 5 (07) : 1003 - 1007
  • [23] Virus-encoded proteinases of the picornavirus super-group
    Ryan, MD
    Flint, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 1997, 78 : 699 - 723
  • [24] CLEAVAGE OF FOOT-AND-MOUTH-DISEASE VIRUS POLYPROTEIN IS MEDIATED BY RESIDUES LOCATED WITHIN A 19 AMINO-ACID-SEQUENCE
    RYAN, MD
    KING, AMQ
    THOMAS, GP
    [J]. JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 2727 - 2732
  • [25] Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs
    Sorrentino, BR
    [J]. NATURE REVIEWS CANCER, 2002, 2 (06) : 431 - 441
  • [26] Development of high-titer retroviral producer cell lines by using Cre-mediated recombination
    Vanin, EF
    Cerruti, L
    Tran, N
    Grosveld, G
    Cunningham, JM
    Jane, SM
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (10) : 7820 - 7826
  • [27] Vignali DAA, 1999, J IMMUNOL, V162, P1431
  • [28] Wang BP, 1999, J IMMUNOL, V162, P88
  • [29] Development of a VSV-G protein pseudotyped retroviral vector system expressing dominant oncogenes from a lacO-modified inducible LTR promoter
    Wang, SJ
    Beattie, GM
    Hayek, A
    Levine, F
    [J]. GENE, 1996, 182 (1-2) : 145 - 150
  • [30] CONSTRUCTION AND CHARACTERIZATION OF RETROVIRAL VECTORS EXPRESSING BIOLOGICALLY-ACTIVE HUMAN INTERLEUKIN-12
    ZITVOGEL, L
    TAHARA, H
    CAI, Q
    STORKUS, WJ
    MULLER, G
    WOLF, SF
    GATELY, M
    ROBBINS, PD
    LOTZE, MT
    [J]. HUMAN GENE THERAPY, 1994, 5 (12) : 1493 - 1506